Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-02-01

Clinical Trial Update: Monitoring Necrotizing Enterocolitis in Premature Infants

View source ↗

Summary

An ongoing clinical trial sponsored by Spectros Corporation focuses on monitoring Necrotizing enterocolitis in premature infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Spectros Corporation | Conditions: Necrotizing Enterocolitis | Status: UNKNOWN